Regulatory perspectives on next-generation sequencing and complementary diagnostics in Japan-Reference-Cited by-同舟云学术

Regulatory perspectives on next-generation sequencing and complementary diagnostics in Japan

Published:2020-02-17 Issue:6 Volume:20 Page:601-610
ISSN:1473-7159
Container-title:Expert Review of Molecular Diagnostics
language:en
Short-container-title:Expert Review of Molecular Diagnostics

Author:

Shimazawa Rumiko¹,Ikeda Masayuki²

Affiliation:

1. Department of Clinical Pharmacology, Tokai University School of Medicine, Isehara, Japan

2. Department of Medical Informatics, Kagawa University Hospital, Takamatsu, Japan

Funder

Japan Society for the Promotion of Science

Publisher

Informa UK Limited

Subject

Genetics,Molecular Biology,Molecular Medicine,Pathology and Forensic Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737159.2020.1728256

Reference91 articles.

1. Preparing for Precision Medicine

2. Government of Japan. Optimal medical treatment for everyone. Available from: https://www.japan.go.jp/tomodachi/2018/Autumn2018/optimal_medical_treatment_for_everyone.html

3. Ministry of Health, Labour and Welfare. The act on securing quality, efficacy and safety of products including pharmaceuticals and medical devices. Available from: http://www.japaneselawtranslation.go.jp/law/detail_main?re=&vm=2&id=3213

4. Pharmaceuticals and Medical Devices Agency. Accreditation of foreign manufacturers. Available from: https://www.pmda.go.jp/english/review-services/reviews/foreign-mfr/0001.html

5. Pharmaceuticals and Medical Devices Agency. Outline of PMDA. Available from: https://www.pmda.go.jp/english/about-pmda/outline/0005.html

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision cancer medicine: What has translated into clinical use in Belgium?;Seminars in Cancer Biology;2021-06

2. Companion and complementary diagnostics: an important treatment decision tool in precision medicine;Expert Review of Molecular Diagnostics;2020-05-05